The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review

Ovarian cancer is the leading cause of mortality among gynecologic malignancies, with most cases diagnosed at an advanced stage. Despite an initial response, most develop a recurrence and subsequent resistance to standard therapies. Pemetrexed (Alimta(TM)) is a new generation multi-targeted antifola...

Descripción completa

Detalles Bibliográficos
Autores principales: Roche, Michael, Parisi, Laura, Li, Linda, Knehans, Amy, Phaeton, Rebecca, Kesterson, Joshua P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007165/
https://www.ncbi.nlm.nih.gov/pubmed/29983902
http://dx.doi.org/10.4081/oncol.2018.346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007165/
https://www.ncbi.nlm.nih.gov/pubmed/29983902
http://dx.doi.org/10.4081/oncol.2018.346

Ejemplares similares